•
Zawada ET Jr: Renal consequences of nonsteroidal antiinflammatory drugs. Postgrad Med. 1982 May;71(5):223-30. Pubmed•
Bergner T, Przybilla B: Photosensitization caused by ibuprofen. J Am Acad Dermatol. 1992 Jan;26(1):114-6. Pubmed•
Chen H, Jacobs E, Schwarzschild MA, McCullough ML, Calle EE, Thun MJ, Ascherio A: Nonsteroidal antiinflammatory drug use and the risk for Parkinson's disease. Ann Neurol. 2005 Dec;58(6):963-7. Pubmed•
Townsend KP, Pratico D: Novel therapeutic opportunities for Alzheimer's disease: focus on nonsteroidal anti-inflammatory drugs. FASEB J. 2005 Oct;19(12):1592-601. Pubmed•
Geisslinger G, Dietzel K, Bezler H, Nuernberg B, Brune K: Therapeutically relevant differences in the pharmacokinetical and pharmaceutical behavior of ibuprofen lysinate as compared to ibuprofen acid. Int J Clin Pharmacol Ther Toxicol. 1989 Jul;27(7):324-8. Pubmed• Noreen Y, et al. J Nat Prod, 1998, 61(1), 2-7.
• Driban JB, et al. J Biomed Biotechnol, 2011, 2011, 691412-691428.
• Palayoor ST, et al. Oncogene, 1999, 18(51), 7389-7394.
• Khwaja F, et al. Cancer Res, 2004, 64(17), 6207-6213.
• Rao GH, et al. Arteriosclerosis, 1983, 3(4), 383-388.
• Davies, N.M., et al.: Clin. Pharmacokinet., 34, 101 (1986)
• Busson, M., et al.: J. Int. Med Res., 14, 53 (1986)
• Meade, E.A., et al.: J. Biol. Chem., 268, 6610 (1986)
• Hiyama, T. et al., Synthesis, 1986, 645, (synth)
• Kaiser, D.G. et al., J. Pharm. Sci., 1976, 65, 269, (resoln, glc, bibl)
• Nicoll-Griffith, D.A., J. Chromatogr., 1987, 402, 179, (resoln)
• Eur. Pat., 1988, Gist-Brocades; Shell Int. Res., 274 146; CA, 110, 113203, (dexibuprofen lysine)
• Shankland, N. et al., Acta Cryst. C, 1997, 53, 951-954, (cryst struct)
• McConnell, J.F., Cryst. Struct. Commun., 1974, 3, 73, (cryst struct)
• Davies, N.M. et al., Clin. Pharmacokinet., 1998, 34, 101-154, (rev)
• U.K. Pat., 1964, 971 700; CA, 61, 14591, (synth, pharmacol)
• Aldrich Library of 13C and 1H FT NMR Spectra, 1992, 2, 1011B, (nmr)
• Negwer, M., Organic-Chemical Drugs and their Synonyms, 6th edn., Akademie-Verlag, 1987, 2867, (synonyms)
• Gonzalez, A., Synth. Commun., 1991, 21, 1353, (synth)
• Nicholson, J.S., Chron. Drug Discovery, 1982, 1, 149, (rev)
• Freer, A.A., Acta Cryst. C, 1993, 49, 1378, (cryst struct)
• Lalonde, J.J. et al., J.A.C.S., 1995, 117, 6845, (resoln)
• Higgins, J.D. et al., Anal. Profiles Drug Subst., 2001, 27, 265-300, (rev)
• Ghislandi, V. et al., Farmaco, Ed. Sci., 1982, 37, 81, (abs config)
• Gruber, K. et al., Arzneim.-Forsch., 1983, 33, 1176, (pharmacol, tox)
• Sonawane, H.R. et al., Tetrahedron, 1994, 50, 1243, (synth)
• Adams, S.S. et al., Arch. Int. Pharmacodyn. Ther., 1969, 178, 115
• Adams, S.S. et al., Toxicol. Appl. Pharmacol., 1969, 15, 310, (metab, tox)
• Ger. Pat., 1975, 2 508 895; CA, 84, 5394, (lysine, salt)
• Yamauchi, T. et al., Synthesis, 1986, 1044, (synth)
• Martindale, The Extra Pharmacopoeia, 31st edn., Pharmaceutical Press, 1996, 50
• Shiori, T. et al., J.O.C., 1978, 43, 2936, (synth)
• Wolber, E.K.A. et al., Chem. Ber., 1991, 124, 1667, (synth, pmr)
有害性 (Xn)
环境危害性 (N)
